Results 131 to 140 of about 19,382 (245)

Long‐term benefit from adjuvant tamoxifen therapy for ER+ HER2− breast cancer by PR positivity

open access: yesInternational Journal of Cancer, Volume 159, Issue 2, Page 450-459, 15 July 2026.
What's new? Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer. Its long‐term benefits, however, may vary by progesterone receptor (PR) status. Here, using data from the Stockholm tamoxifen trials, the authors evaluated whether PR expression predicts
Anna E. Nordenskjöld   +8 more
wiley   +1 more source

Altered Body Image Following Radical Mastectomy [PDF]

open access: yes, 1965
The purpose of this study was to identify reactions and adjustments to the altered body image following radical mastectomy. It was felt that nurses could be of more assistance to women facing this experience if they knew and understood the common ...
McConnell, Julia Lee Anne
core   +1 more source

THE RATIONALE OF RADICAL MASTECTOMY

open access: yesAnnals of Surgery, 1951
D H, SPRONG, W F, POLLOCK
openaire   +3 more sources

Surgical Decision-Making in Breast Cancer: A Retrospective Comparative Study from a Tertiary Center. [PDF]

open access: yesJ Clin Med
Bobirca F   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy